logo
welcome
Reuters

Reuters

Novavax to sell Czech manufacturing unit to Novo Nordisk for $200 million

Reuters
Summary
Nutrition label

80% Informative

COVID-19 vaccine maker Novavax said it will sell its manufacturing facility in Czech Republic to Wegovy-maker Novo Nordisk for $200 million .

The company has struggled to keep pace with rival vaccine makers Moderna and Pfizer .

It had raised doubts about its ability to stay in business in 2023 .

The sale of the unit will result in annual operating cost reductions of about $80 million .

VR Score

90

Informative language

95

Neutral language

70

Article tone

formal

Language

English

Language complexity

60

Offensive language

not offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

short-lived

External references

no external sources

Source diversity

no sources

Affiliate links

no affiliate links